News T2 Biosystems, Inc.

Equities

TTOO

US89853L3024

Delayed Nasdaq Other stock markets 11:25:20 2024-04-24 am EDT			5-day change	1st Jan Change
2.64 ^USD	-2.94%		-10.20%	-57.93%

Apr. 23	Top Premarket Decliners	MT
Apr. 01	T2 Biosystems, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

T2 Biosystems to Report First Quarter 2024 Financial Results and Business Updates on May 6, 2024	09:01am	AQ
Top Premarket Decliners	Apr. 23	MT
T2 Biosystems Shareholders Vote for CRG Debt Conversion into Equity	Apr. 11	AQ
T2 Biosystems, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Apr. 01	CI
T2 Biosystems Announces Extension of Multi-Year Capital Equipment Supplier Agreement with Vizient, Inc.	Mar. 28	AQ
T2 Biosystems Announces Extension of Multi-Year Capital Equipment Supplier Agreement with Vizient, Inc	Mar. 28	CI
T2 Biosystems, Inc. Reiterates Revenue Guidance for the Year 2024	Mar. 20	CI
Transcript : T2 Biosystems, Inc. - Special Call	Mar. 20
T2 Biosystems Unveils T2Lyme Launch Plans and Provides Additional Business Updates	Mar. 20	AQ
T2 Biosystems Unveils T2Lyme Launch Plans and Provides Additional Business Updates	Mar. 20	CI
T2 Biosystems to Host Investor Call on March 20, 2024 to Unveil its T2Lyme Launch Plans and Provide Additional Business Updates	Mar. 19	AQ
T2 Biosystems Announces New Publication Highlighting the Clinical Benefits and Performance of the T2Resistance Panel	Mar. 18	AQ
T2 Biosystems, Inc. Announces Publication of New Study Highlighting Clinical Benefits and Performance of Real-World Use of T2Resistance Panel in Journal of Clinical Microbiology	Mar. 18	CI
T2 Biosystems Receives Extension to Comply with Nasdaq Listing Requirement	Mar. 12	AQ
Transcript : T2 Biosystems, Inc., Q4 2023 Earnings Call, Feb 15, 2024	Feb. 15
T2 Biosystems Announces Preliminary Fourth Quarter and Full Year 2023 Financial Results	Feb. 15	AQ
T2 Biosystems Announces Agreement with CRG for the Conversion of $15 Million of CRG Term Loan into Equity	Feb. 15	AQ
T2 Biosystems Announces Commercial Expansion Through Distributors in Europe and Asia	Feb. 15	AQ
T2 Biosystems, Inc. Announces Commercial Expansion Through Distributors in Europe and Asia	Feb. 15	CI
Sector Update: Health Care Stocks Mixed Late Afternoon	Feb. 12	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News T2 Biosystems, Inc.

Equities

TTOO

US89853L3024

Summary

Filters